
Our Research & Development organization brings together the best minds in life science innovation. The teams located in facilities in Lexington, Watertown, Cambridge and Plainsboro reflect the full R&D continuum, from early research through late-stage clinical development. Here, we are building for the future, creating a distinct R&D community based on collaboration, partnerships, and cutting-edge research across multiple modalities and therapeutic areas. We recognize that improving human health starts here and that patients rely on us. Our R&D hub merges biotech speed and agility with large pharmaceutical company quality, resources, and stability, uniting the best of both worlds to develop new medicines for patients.
The Global Project Leader (GPL) Metabolic Diseases for Early Portfolio is responsible for enterprise leadership of highly complex product project(s) with significant business impact for Novo Nordisk (NN). The project may consist of a single late-stage project or multiple early-stage projects. The GPL owns the full product development lifecycle, including long-term decisions and their implications and requires a broad T-profile across the Novo Nordisk value chain: sufficient specialist depth to understand scientific, regulatory, commercial, manufacturing and operational realities, combined with breadth to connect functions, shape options and set direction across the enterprise. This responsibility includes setting a high level of ambition for outcomes, value creation and overall project impact; defining project strategies and plans; leading through the matrix rather than formal authority; and interacting independently with executive and senior leadership as well as taking leadership for one or more GPTs.
Reports to the Portfolio Vice President. Internal Key Stakeholders: R&D Leadership Team, Senior Leadership Teams across EVP areas, Executive Management, Global Project Leaders and GPT members, Project Governance Committees and TAPGs, Key functions including P&PS and GMS, International and US Operations, Finance, Legal and Global Solutions. External Key Stakeholders: Health authorities (e.g. EMA, FDA, CHMP, PMDA), Advisory boards, ethics committees, key opinion leaders, investigators, CROs, vendors and other partners. External interactions include Health Authorities (e.g. EMA, FDA, CHMP, PMDA), Global Advisory Boards, Ethics Committees, Key Opinion Leaders, Investigators, CROs, vendors, in general world-wide. Proactive and responsible member of the Portfolio VP Management team. The job function requires a very high degree of independence and decisions taken have a high degree of business impact. Independence and initiative should always be demonstrated when planning and prioritizing tasks and be in accordance with the current PDP as well as in accordance with Novo Nordisk clinical trial SOPs, applicable Novo Nordisk policies and “The Novo Nordisk Way”.
The Global Project Leader position is based in Boston or Plainsboro as part of Research & Development with a global impact/influence through the execution of the development project via the R&D organization and interaction with external advisors and regulatory authorities worldwide. Domestic and International travel will be required.
The base compensation range for this position is $229,200 to $401,100. Base compensation is determined based on a number of factors. This position is also eligible for a company bonus based on individual and company performance. Novo Nordisk offers long-term incentive compensation and or company vehicles depending on the position's level or other company factors.
Employees are also eligible to participate in Company employee benefit programs including medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; employee assistance program; tuition reimbursement program; and voluntary benefits such as group legal, critical illness, identity theft protection, pet insurance and auto/home insurance. The Company also offers time off pursuant to its sick time policy, flex-able vacation policy and parental leave policy.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
At Novo Nordisk, we're not chasing quick fixes – we're creating lasting change for long-term health. For over 100 years, we've been driven by a single purpose: to defeat serious chronic diseases and help millions of people live healthier lives. This dedication fuels our constant curiosity and inspires us to push the boundaries of what's possible in healthcare. We embrace diverse perspectives, seek out bold ideas, and build partnerships rooted in shared purpose. Together, we're making healthcare more accessible, treating and defeating diseases, and pioneering solutions that create change spanning generations. When you join us, you become part of something bigger – a legacy of impact that reaches far beyond today.
Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.
If you are interested in applying to Novo Nordisk and need special assistance or an accommodation to apply, please call us at 1-855-411-5290. This contact is for accommodation requests only and cannot be used to inquire about the status of applications.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html